Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 7.292 Q1 | 391 | 165 | 659 | 8590 | 5817 | 345 | 12.24 | 52.06 | |
2 | Trends in Pharmacological Sciences | journal | 4.697 Q1 | 244 | 88 | 301 | 5411 | 2916 | 282 | 9.90 | 61.49 | |
3 | Advanced Drug Delivery Reviews | journal | 3.144 Q1 | 366 | 140 | 369 | 14876 | 3511 | 310 | 8.31 | 106.26 | |
4 | Critical Reviews in Toxicology | journal | 2.095 Q1 | 129 | 44 | 97 | 5208 | 694 | 91 | 7.31 | 118.36 | |
5 | Current Opinion in Pharmacology | journal | 3.008 Q1 | 148 | 109 | 296 | 5522 | 2020 | 264 | 6.74 | 50.66 | |
6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.780 Q1 | 70 | 5 | 25 | 733 | 150 | 25 | 6.47 | 146.60 | |
7 | Particle and Fibre Toxicology | journal | 2.227 Q1 | 119 | 22 | 38 | 762 | 330 | 38 | 6.44 | 34.64 | |
8 | Natural Product Reports | journal | 2.918 Q1 | 211 | 58 | 167 | 8919 | 1101 | 162 | 6.38 | 153.78 | |
9 | Neuropsychopharmacology | journal | 3.385 Q1 | 249 | 303 | 770 | 19353 | 5141 | 742 | 6.37 | 63.87 | |
10 | Cellular and Molecular Life Sciences | journal | 3.544 Q1 | 261 | 310 | 804 | 31629 | 4941 | 799 | 5.91 | 102.03 | |
11 | Pharmacogenomics Journal | journal | 1.911 Q1 | 95 | 49 | 142 | 2125 | 902 | 140 | 5.87 | 43.37 | |
12 | Drug Discovery Today | journal | 2.001 Q1 | 215 | 150 | 629 | 8163 | 3122 | 570 | 5.62 | 54.42 | |
13 | Journal of Controlled Release | journal | 2.272 Q1 | 313 | 274 | 1054 | 11328 | 5717 | 1045 | 5.20 | 41.34 | |
14 | Current Drug Metabolism | journal | 1.182 Q1 | 122 | 114 | 183 | 11387 | 1012 | 177 | 5.06 | 99.89 | |
15 | Clinical Pharmacokinetics | journal | 1.480 Q1 | 184 | 62 | 236 | 4132 | 1372 | 224 | 5.00 | 66.65 | |
16 | Nano Today | journal | 3.370 Q1 | 175 | 21 | 67 | 977 | 323 | 40 | 4.82 | 46.52 | |
17 | Toxicological Sciences | journal | 1.752 Q1 | 207 | 260 | 970 | 12280 | 4526 | 937 | 4.79 | 47.23 | |
18 | Neurotherapeutics | journal | 2.162 Q1 | 136 | 65 | 191 | 5266 | 1146 | 175 | 4.68 | 81.02 | |
19 | Psychopharmacology | journal | 2.275 Q1 | 214 | 337 | 1187 | 19946 | 5614 | 1147 | 4.67 | 59.19 | |
20 | Current Opinion in Drug Discovery and Development | journal | 1.394 Q1 | 85 | 74 | 214 | 4597 | 883 | 196 | 4.35 | 62.12 | |
21 | Journal of Molecular Medicine | journal | 2.379 Q1 | 157 | 137 | 375 | 6799 | 1835 | 353 | 4.31 | 49.63 | |
22 | Apoptosis : an international journal on programmed cell death | journal | 2.081 Q1 | 128 | 131 | 507 | 6590 | 2045 | 503 | 4.17 | 50.31 | |
23 | Journal of Nanobiotechnology | journal | 1.400 Q1 | 109 | 14 | 34 | 457 | 165 | 32 | 4.12 | 32.64 | |
24 | Journal of Antimicrobial Chemotherapy | journal | 2.076 Q1 | 221 | 563 | 1439 | 13976 | 5985 | 1174 | 3.99 | 24.82 | |
25 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 117 | 173 | 445 | 12481 | 1750 | 418 | 3.98 | 72.14 | |
26 | European Journal of Pharmaceutical Sciences | journal | 1.022 Q1 | 163 | 128 | 549 | 4033 | 1682 | 542 | 3.93 | 31.51 | |
27 | International Journal of Neuropsychopharmacology | journal | 1.843 Q1 | 125 | 109 | 258 | 5846 | 1071 | 226 | 3.88 | 53.63 | |
28 | Nanotoxicology | journal | 1.034 Q1 | 107 | 25 | 26 | 1137 | 100 | 25 | 3.85 | 45.48 | |
29 | Expert Opinion on Therapeutic Targets | journal | 1.533 Q1 | 106 | 127 | 307 | 12944 | 1104 | 285 | 3.83 | 101.92 | |
30 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.323 Q1 | 185 | 328 | 459 | 11602 | 1842 | 453 | 3.80 | 35.37 | |
31 | Investigational New Drugs | journal | 1.323 Q1 | 97 | 68 | 202 | 1974 | 793 | 199 | 3.80 | 29.03 | |
32 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.204 Q1 | 99 | 28 | 53 | 5091 | 239 | 50 | 3.78 | 181.82 | |
33 | Expert Opinion on Biological Therapy | journal | 1.198 Q1 | 102 | 171 | 423 | 14412 | 1417 | 421 | 3.76 | 84.28 | |
34 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.952 Q2 | 100 | 123 | 187 | 10962 | 769 | 182 | 3.74 | 89.12 | |
35 | European Neuropsychopharmacology | journal | 1.507 Q1 | 130 | 117 | 279 | 6132 | 1230 | 274 | 3.72 | 52.41 | |
36 | Antiviral Research | journal | 1.194 Q1 | 151 | 137 | 307 | 6455 | 1179 | 305 | 3.69 | 47.12 | |
37 | Drug and Alcohol Dependence | journal | 1.874 Q1 | 187 | 250 | 635 | 11420 | 2558 | 618 | 3.69 | 45.68 | |
38 | Antiviral Therapy | journal | 1.698 Q1 | 93 | 143 | 402 | 4971 | 1565 | 395 | 3.68 | 34.76 | |
39 | Neuropharmacology | journal | 1.797 Q1 | 191 | 296 | 754 | 16460 | 2883 | 752 | 3.65 | 55.61 | |
40 | Current Opinion in Investigational Drugs | journal | 1.135 Q1 | 83 | 126 | 393 | 8936 | 1223 | 361 | 3.56 | 70.92 | |
41 | Chemico-Biological Interactions | journal | 0.961 Q2 | 144 | 217 | 482 | 8163 | 1520 | 477 | 3.52 | 37.62 | |
42 | Journal of Psychopharmacology | journal | 1.428 Q1 | 135 | 142 | 372 | 6060 | 1405 | 323 | 3.51 | 42.68 | |
43 | Pharmacogenomics | journal | 0.988 Q2 | 100 | 182 | 375 | 9640 | 1277 | 331 | 3.49 | 52.97 | |
44 | Environmental Pollution | journal | 1.922 Q1 | 301 | 531 | 1224 | 22527 | 4589 | 1207 | 3.47 | 42.42 | |
45 | Expert Opinion on Emerging Drugs | journal | 0.986 Q2 | 54 | 43 | 144 | 5144 | 459 | 144 | 3.44 | 119.63 | |
46 | Drug Safety | journal | 1.221 Q1 | 140 | 104 | 287 | 4704 | 1111 | 249 | 3.42 | 45.23 | |
47 | International Journal of Pharmaceutics | journal | 1.227 Q1 | 258 | 655 | 1509 | 21603 | 5419 | 1496 | 3.39 | 32.98 | |
48 | Expert Opinion on Drug Delivery | journal | 0.942 Q1 | 133 | 98 | 201 | 9837 | 652 | 190 | 3.37 | 100.38 | |
49 | Toxicological Reviews | journal | 0.686 Q2 | 49 | 0 | 49 | 0 | 165 | 42 | 3.35 | 0.00 | |
50 | Journal of Computer-Aided Molecular Design | journal | 0.989 Q2 | 119 | 83 | 175 | 3201 | 576 | 172 | 3.32 | 38.57 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®